Friday, November 6, 2009

Animal Products (Contaminants) in Vaccinations

Animal products in vaccination: Monkey kidney cells, sheep red blood cells, chick embryonic fluid, fetal bovine serum, bovine gelatin, guinea pig embryo cells= risk and history of contamination.

http://www.sailhome.org/Concerns/Vaccines.html

Calf fetus, chick embryo, chick kidney, chicken egg, cow heart, dog kidney, duck egg, guinea pig embryo, horse blood, monkey kidney, monkey lung, mouse blood, pig blood, rabbit brain, sheep blood and others. These are used in various vaccine production lines. Residues are not completely purified out of the final packaged product. Contamination can introduce new pathogens.

Studies of contamination via animal products in vaccinations:

Wessman SJ, Levings RL. Benefits and risks due to animal serum used in cell culture production, Dev Biol Stand. 1999;99:3-8.

Excerpt: Infection with bovine viral diarrhoea virus (BVDV) and other viruses is frequent in the bovine population. In utero infection leads to virus and antibody contamination of foetal and other serum used in cell culture production. The use of contaminated cells for vaccine production may result in contaminated vaccines.

Schuurman R, van Steenis B, Frequent detection of bovine polyomavirus in commercial batches of calf serum by using the polymerase chain reaction, J Gen Virol. 1991 Nov;72 ( Pt 11):2739-45.

Excerpt: The results indicate that the use of calf serum to supplement tissue culture media involves a serious risk of contaminating cell cultures with BPyV.

Johnson JA, Heneine W. Characterization of endogenous avian leukosis viruses in chicken embryonic fibroblast substrates used in production of measles and mumps vaccines. J Virol. 2001 Apr;75(8):3605-12.

Johnson ES.Poultry oncogenic retroviruses and humans. Cancer Detect Prev. 1994;18(1):9-30.Harris RJ, Dougherty RM, Contaminant viruses in two live virus vaccines produced in chick cells. J Hyg (Lond). 1966 Mar;64(1):1-7.

Contreras G, Bather R, Activation of metastatic potential in African green monkey kidney cell lines by prolonged in vitro culture. In Vitro Cell Dev Biol. 1985 Nov;21(11):649-52.

Schuurman R, van Steenis B, Bovine polyomavirus, a frequent contaminant of calf serum. Biologicals. 1991 Oct;19(4):265-70.

Wang J, Horner GW, Detection and molecular characterisation of bovine polyomavirus in bovine sera in New Zealand.N Z Vet J. 2005 Feb;53(1):26-30.

van der Noordaa J, Sol CJ, Bovine polyomavirus, a frequent contaminant of calf sera; Dev Biol Stand. 1999;99:45-7.

Monkey kidney cells and SV40 contamination in Polio vaccines:

***Polio vaccine has also been definitively linked to carcinogen SV-40. Unfortunately some bad monkey kidney cells happened to contaminate many batches of Polio vaccines (since that is one of the ingredients in the polio vaccine) and this has caused a prominant incidence of Cancer in the United States because of the nature of this contamination.

Below is documentation regarding the connection.

http://thinktwice.com/s_polio.htm

1. Monkey kidneys are used to develop polio vaccines.
2. SV-40, a cancer-causing virus, thrived in monkey kidneys.
3. Polio vaccines were contaminated.
4. Millions of people in the USA and throughout the world were infected.
5. Cancer rates have increased. SV-40 is found in brain tumors, bone cancers, lung cancers, and leukemia.

The Polio Vaccine Has Been Linked to Cancer:

Shah, K and Nathanson, N. "Human exposure to SV40." American Journal of Epidemiology, 1976; 103: 1-12.

Innis, M.D. "Oncogenesis and poliomyelitis vaccine." Nature, 1968; 219:972-73.

Soriano, F., et al. "Simian virus 40 in a human cancer." Nature, 1974; 249:421-24.

Weiss, A.F., et a;. "Simian virus 40-related antigens in three human meningiomas with defined chromosome loss." Proceedings of the National Academy of Science 1975; 72(2):609-13.

Scherneck, S., et al. "Isolation of a SV-40-like papovavirus from a human glioblastoma." International Journal of Cancer 1979; 24:523-31.

Stoian, M., et al. "Possible relation between viruses and oromaxillofacial tumors. II. Research on the presence of SV40 antigen and specific antibodies in patients with oromaxillofacial tumors." Virologie, 1987; 38:35-40.

Stoian, M., et al. "Possible relation between viruses and oromaxillofacial tumors. II. Detection of SV40 antigen and of anti-SV40 antibodies in patients with parotid gland tumors." Virologie, 1987; 38:41-46.

Bravo, M.P., et al. "Association between the occurrence of antibodies to simian vacuolating virus 40 and bladder cancer in male smokers." Neoplasma, 1988; 35:285-88.

O'Connell, K., et al. "Endothelial cells transformed by SV40 T-antigen cause Kaposi?s sarcoma-like tumors in nude mice." American Journal of Pathology, 1991; 139(4):743-49.

Weiner, L.P., et al. "Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy." New England Journal of Medicine, 1972; 286:385-90.

Tabuchi, K. "Screening of human brain tumors for SV-40-related T-antigen." International Journal of Cancer 1978; 21:12-17.

Meinke, W., et al. "Simian virus 40-related DNA sequences in a human brain tumor." Neurology 1979; 29:1590-94.

Krieg, P., et al. "Episomal Simian Virus 40 Genomes in Human Brain Tumors." Proceedings of the National Academy of Sciences of the USA, 1981, 78(10):6446-6450.

Krieg, P., et al. "Cloning of SV40 genomes from human brain tumors." Virology 1984; 138:336-40.

Geissler, E. "SV40 in human intracranial tumors: passenger virus or oncogenic 'hit-and-run' agent?" Z Klin Med, 1986; 41:493-95.

Geissler, E. "SV40 and Human Brain Tumors." Progress in Medical Virology, 1990; 37:211-222.

Bergsagel, D.J., et al. "DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood." New England Journal of Medicine, 1992; 326:988-93.

Martini, M., et al. "Human Brain Tumors and Simian Virus 40." Journal of the National Cancer Institute, 1995, 87(17):1331.

Lednicky, JA., et al. "Natural Simian Virus 40 Strains are Present in Human Choroid Plexus and Ependymoma Tumors." Virology, 1995, 212(2):710-17.

Tognon, M., et al. "Large T Antigen Coding Sequence of Two DNA Tumor Viruses, BK and SV-40, and Nonrandom Chromosome Changes in Two Gioblastoma Cell Lines." Cancer Genetics and Cytogenics, 1996, 90(1): 17-23.

Carbone, M., et al. "SV-40 Like Sequences in Human Bone Tumors." Oncogene, 1996, 13(3):527-35.

Pass, HI,, et al. "Evidence For and Implications of SV-40 Like Sequences in Human Mesotheliomas." Important Advances in Oncology, 1996, pp. 89-108.

Rock, Andrea. "The Lethal Dangers of the Billion Dollar Vaccine Business," Money, (December 1996), p. 161. [Article]

Carlsen, William. "Rogue virus in the vaccine: Early polio vaccine harbored virus now feared to cause cancer in humans." San Francisco Chronicle (July 15, 2001), p. 7. [Article: Research by Susan Fisher, epidemiologist, Loyola University Medical Center.]

Bookchin, D. and Schumacher J. "Tainted polio vaccine still carries its threat 40 years later." The Boston Globe (January 26, 1997). [Article]

Rosa, FW., et al. "Absence of antibody response to simian virus 40 after inoculation with killed-poliovirus vaccine of mothers offspring with neurological tumors." New England Journal of Medicine, 1988; 318:1469.

Rosa, FW., et al. Response to: "Neurological tumors in offspring after inoculation of mothers with killed poliovirus vaccine." New England Journal of Medicine, 1988, 319:1226.

Martini, F., et al. "SV-40 Early Region and Large T Antigen in Human Brain Tumors, Peripheral Blood Cells, and Sperm Fluids from Healthy Individuals." Cancer Research, 1996, 56(20):4820-4825.

1 comment:

  1. Apologies that the editor here on blogspot does not allow me edit out the underlines, although I did edit them out on the word document before posting and they still showed up.

    ReplyDelete